Food and Drug Administration

Dermatologic and Ophthalmic Drugs Advisory Committee Meeting

Open Public Hearing

May 23, 2002

Testimony to the FDA Dermatologic and Ophthalmic Drugs Advisory Committee, Gail Zimmerman, Nat'l Psoriasis Foundation htm  ppt